Skip to content

Net Income at other companies

3M logo
3MMMM
$659M-41.3%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$78.69M-46.3%
Biogen logo
BiogenBIIB
$319.5M+32.8%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$164M+128%
Entegris logo
EntegrisENTG
$92M+46.3%
Chemours logo
ChemoursCC
-$29M-480%

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's net income?
Rogers Corporation (ROG) reported net income of $4.5M in Q1 2026.
How has Rogers Corporation's net income changed year-over-year?
Rogers Corporation's net income increased by 421.4% year-over-year, from -$1.4M to $4.5M.
What is the long-term trend for Rogers Corporation's net income?
Over 4 years (2021 to 2025), Rogers Corporation's net income has grown at a -11.5% compound annual growth rate (CAGR), from $108.1M to -$66.4M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.